secwatch / observer
8-K filed June 16, 2022, 7:59 PM ET ticker VANI CIK 0001266806
leadership confidence high sentiment neutral materiality 0.50

VP Clinical and Scientific Affairs Jessy Dorn resigns effective July 15, 2022

Vivani Medical, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jessy Dorn

Vice President, Clinical and Scientific Affairs
VANI · Vivani Medical, Inc.
Effective
2022-07-15
Filed
June 16, 2022, 7:59 PM ET
On June 13, 2022, Second Sight Medical Products, Inc. received notice from Dr. Jessy Dorn, its Vice President, Clinical and Scientific Affairs, that she will resign from her current position effective July 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jessy Dorn resigned as Vice President, Clinical and Scientific Affairs at Vivani Medical, Inc..

Action
resigned
Role
Vice President, Clinical and Scientific Affairs
Exact text from the filing
On June 13, 2022, Second Sight Medical Products, Inc. received notice from Dr. Jessy Dorn, its Vice President, Clinical and Scientific Affairs, that she will resign from her current position effective July 15, 2022.
View on SEC.gov

Vivani Medical, Inc. filing history →

Source: SEC EDGAR
accession 0001753926-22-000875
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.